Physician profile
Steven Deitch
NPI 1033125174
$915.55
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.34 · 2020: $16.92 · 2021: $75.50 · 2022: $391 · 2023: $191 · 2024: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $145.62 | 2024 | Inbone |
| Organogenesis INC. | $137.71 | 2021-2022 | |
| Medtronic, INC. | $127.69 | 2022 | |
| Integra Lifesciences Corporation | $81.37 | 2019-2022 | |
| Smith+Nephew, INC. | $68.64 | 2023-2024 | Grafix Pl, Stravix Pl, Grafix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.22 | 2021-2023 | Jublia |
| Nevro Corp. | $50.61 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $47.34 | 2023 | Krystexxa |
| Depuy Synthes Sales INC. | $32.74 | 2022 | |
| Zimmer Biomet Holdings, INC. | $31.46 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $29.20 | 2022-2023 | Nuzyra |
| Medshape, INC. | $26.12 | 2023 | Dynanail Helix, Washer, 15 Mm |
| Bioventus LLC | $17.81 | 2022 | |
| Heron Therapeutics, INC. | $15.93 | 2021 | |
| Averitas Pharma INC. | $15.56 | 2024 | Qutenza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.00 | 2019 | |
| Orpyx Medical Technologies US INC. | $13.53 | 2023 | Orpyx Si |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Deitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.